ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Gut microbial metabolite hyodeoxycholic acid targets the TLR4/MD2 complex to attenuate inflammation and protect against sepsis

Li, Jiaxin; Chen, Yuqi; Li, Rui; Zhang, Xianglong; Chen, Tao; Mei, Fengyi; Liu, Ruofan; Chen, Meiling; Ge, Yue; Hu, Hongbin; Wei, Rongjuan; Chen, Zhenfeng; Fan, Hongying; Zeng, Zhenhua; Deng, Yongqiang; Luo, Haihua; Hu, Shuiwang; Cai, Shumin; Wu, Feng; Shi, Nengxian; Wang, Zhang; Zeng, Yunong; Xie, Ming; Jiang, Yong; Chen, Zhongqing*; Jia, Wei*; Chen, Peng*南方医科大学; 上海交通大学; 6
Molecular Therapy2023-4-5DOI: 10.1016/j.ymthe.2023.01.018
8被引9阅读
引用收藏
分享

摘要

Sepsis, a critical condition resulting from the systemic inflam-matory response to a severe microbial infection, represents a global public health challenge. However, effective treatment or intervention to prevent and combat sepsis is still lacking. Here, we report that hyodeoxycholic acid (HDCA) has excellent anti-inflammatory properties in sepsis. We discovered that the plasma concentration of HDCA was remarkably lower in patients with sepsis and negatively correlated with the severity of the disease. Similar changes in HDCA levels in plasma and cecal content samples were observed in a mouse model of sepsis, and these changes were associated with a reduced abundance of HDCA-producing strains. Interestingly, HDCA administration significantly decreased systemic inflammatory responses, prevented organ injury, and prolonged the survival of septic mice. We demonstrated that HDCA suppressed excessive activation of inflammatory macrophages by competitively blocking lipopolysaccharide binding to the Toll-like receptor 4 (TLR4) and myeloid differentiation factor 2 receptor complex, a unique mechanism that characterizes HDCA as an endogenous inhibitor of inflammatory signaling. Additionally, we verified these findings in TLR4 knockout mice. Our study highlights the potential value of HDCA as a therapeutic molecule for sepsis.

学科与关键词

关键词
LITHOCHOLIC ACIDBILE-ACIDSBIOTRANSFORMATIONPLASMACELLSLIVERMICE
相关
加载中…
  • Novel tripeptide RKH derived from Akkermansia muciniphila protects against lethal sepsis
    Xie, Shihao; Li, Jiaxin; Lyu, Fengyuan; Xiong, Qingming; Gu, Peng; Chen, Yuqi; Chen, Meiling; Bao, Jingna; Zhang, Xianglong; Wei, Rongjuan; Deng, Youpeng; Wang, Hongzheng; Zeng, Zhenhua; Chen, Zhongqing; Deng, Yongqiang; Lian, Zhuoshi; Zhao, Jie; Gong, Wei; Chen, Ye; Liu, Ke-Xuan; Duan, Yi*; Jiang, Yong*; Zhou, Hong-Wei*; Chen, Peng*Gut, 2023.被引 3
  • Gut microbiota-derived indole 3-propionic acid partially activates aryl hydrocarbon receptor to promote macrophage phagocytosis and attenuate septic injury
    Huang, Zhi-Bin; Hu, Zhen; Lu, Chen-Xin; Luo, Si-Dan; Chen, Yu; Zhou, Zhi-Peng; Hu, Jing-Juan; Zhang, Fang-Ling; Deng, Fan*; Liu, Ke-Xuan*Frontiers in Cellular and Infection Microbiology, 2022, 12: 1015386.被引 9
  • Indole-3-Propionic Acid as a Potential Therapeutic Agent for Sepsis-Induced Gut Microbiota Disturbance
    Fang, Heng; Fang, Miaoxian; Wang, Yirong; Zhang, Huidan; Li, Jiaxin; Chen, Jingchun; Wu, Qingrui; He, Linling; Xu, Jing; Deng, Jia; Liu, Mengting; Deng, Yiyu*; Chen, Chunbo*Microbiology Spectrum, 2022, 10(3).被引 22
查看全部 →

发表信息

论文状态
公开发表
期刊
Molecular Therapy
发表日期
2023-04-05
卷期
第 31 卷, 第 4 期
页码
1017-1032
DOI
10.1016/j.ymthe.2023.01.018
语言
ENGLISH
成果收录
SCIE
资助标注
National Key R&D Program of China [2022YFA0806400]; National Natural Science Foundation of China [81873926, 32071124, 82130063, 81871604]; Special Support Plan for Outstanding Talents of Guangdong Province [2019JC05Y340]; Natural Science Foundation of Guangdong Province [2017A030313590]

作者

  • L

    Li, Jiaxin (第一作者)

    southern med univ

  • C

    Chen, Yuqi

    southern med univ

查看全部 27 位作者收起作者
  • L

    Li, Rui

    southern med univ

  • Z

    Zhang, Xianglong

    southern med univ

  • C

    Chen, Tao

    southern med univ

  • M

    Mei, Fengyi

    southern med univ

  • L

    Liu, Ruofan

    southern med univ

  • C

    Chen, Meiling

    southern med univ

  • G

    Ge, Yue

    southern med univ

  • H

    Hu, Hongbin

    southern med univ

  • W

    Wei, Rongjuan

    southern med univ

  • C

    Chen, Zhenfeng

    southern med univ

  • F

    Fan, Hongying

    southern med univ

  • Z

    Zeng, Zhenhua

    southern med univ

  • D

    Deng, Yongqiang

    southern med univ

  • L

    Luo, Haihua

    southern med univ

  • H

    Hu, Shuiwang

    southern med univ

  • C

    Cai, Shumin

    southern med univ

  • W

    Wu, Feng

    southern med univ

  • S

    Shi, Nengxian

    southern med univ

  • W

    Wang, Zhang

  • Z

    Zeng, Yunong

    southern med univ

  • X

    Xie, Ming

    southern med univ

  • J

    Jiang, Yong

    southern med univ

  • C

    Chen, Zhongqing (通讯)

    southern med univ

  • J

    Jia, Wei (通讯)

    6 · shanghai jiao tong univ · hong kong baptist univ

  • C

    Chen, Peng (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417